| 000 | 01633 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514230613.0 | ||
| 264 | 0 | _c20050916 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a0306-9877 | ||
| 024 | 7 |
_a10.1016/j.mehy.2005.02.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShackelford, Rodney E | |
| 245 | 0 | 0 |
_aPharmacologic manipulation of the ataxia-telangiectasia mutated gene product as an intervention in age-related disease. _h[electronic resource] |
| 260 |
_bMedical hypotheses _c2005 |
||
| 300 |
_a363-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAging |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xmetabolism |
| 650 | 0 | 4 | _aAtaxia Telangiectasia Mutated Proteins |
| 650 | 0 | 4 |
_aCatechin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xgenetics |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGenistein _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aModels, Theoretical |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aOxidants _xmetabolism |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xgenetics |
| 650 | 0 | 4 |
_aQuercetin _xpharmacology |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
| 773 | 0 |
_tMedical hypotheses _gvol. 65 _gno. 2 _gp. 363-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mehy.2005.02.015 _zAvailable from publisher's website |
| 999 |
_c15583384 _d15583384 |
||